Srb Corp Moderna, Inc. Transaction History

Srb Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $26,589 - $38,615	-196 Reduced 8.13%	2,216 $340,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $285,532 - $506,616	2,412 New	2,412 $433,000
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $679,236 - $1.02 Million	5,799 Added 97.89%	11,723 $1.68 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $1.34 Million - $2.18 Million	5,924 New	5,924 $1.5 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Srb Corp, based on Form 13F filings with the SEC.

Stay updated on Srb Corp with notifications on news.